NEOGEN CORP (NEOG) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US6404911066
NEOGEN CORP financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 894.66 m USD | 870.40 m USD |
| Gross profit | 421.38 m USD | 408.50 m USD |
| Operating income | -1.06 bn USD | -21.60 m USD |
| EBIT | -1.09 bn USD | 15.10 m USD |
| Net income | -1.09 bn USD | -7.90 m USD |
| Diluted EPS – continuing operations | -5.03 USD | -0.04 USD |
Full history since 1988, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NEOGEN CORP
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
More stocks
- Maanshan Iron & Steel Co Ltd (600808.SS)
- Wanda Cinema Line Corp (002739.SZ)
- Navan, Inc. (NAVN)
- Liberty Energy Inc. (LBRT)
- Golden Agri-Resources (GARPY)
- RESIDEO TECHNOLOGIES, INC. (REZI)
- Pt Pradiksi Gunatama Tbk (PGUN.JK)
- Merdeka Copper Gold PT (MDKA.JK)
- Caiss Regio Credi Agric Mutuel Paris Idf (CAF.PA)
- Guangzhou Zhujiang Brewery Co Ltd (002461.SZ)
- COL Digital Publishing Group Co Ltd (300364.SZ)
- FULLER H B CO (FUL)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.